Jay Strum, Chief Scientific Officer at G1 Therapeutics, Inc. (GTHX), sold 10,000 shares at $59.10 ($596K) on 2018-08-29, disclosed to the SEC on 2018-08-31.
Open-market sale of $596k GTHX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.40 | 600 | $35K | 5.9% |
| 2 | $59.10 | 3,500 | $207K | 34.7% |
| 3 | $60.00 | 700 | $42K | 7.0% |
| 4 | $61.00 | 200 | $12K | 2.0% |
| 5 | $59.27 | 500 | $30K | 5.0% |
| 6 | $60.05 | 4,500 |
| $270K |
| 45.3% |
| Total | $59.59 avg | 10,000 | $596K | 100% |